Given the differential effects of Lrrk2 mutation across subtypes, we also sought to map the association of gene expression in our dataset with co-expression of PD-associated risk loci identified by GWAS (Nalls et al., 2019) using a polygenic enrichment score method, scDRS (Zhang et al., 2022a). The gene discussed is LRRK2; the disease is Parkinson disease.